Discover our core high-throughput sequencing technologies designed to work in synergy with targeted metabolomics for comprehensive multi-omics analysis.
Targeted metabolomics represents a cornerstone of modern systems biology, enabling the precise, absolute, or relative quantification of a predefined set of chemically characterized and biologically annotated small-molecule metabolites. Unlike untargeted metabolomics, which aims to capture a global and qualitative profile of all detectable compounds in a sample, targeted metabolomics focuses on specific pathways or classes of molecules. These include amino acids, lipids, organic acids, nucleotides, neurotransmitters, and hormones. By employing highly sensitive and selective analytical techniques—most notably Triple Quadrupole Mass Spectrometry (QQQ-MS) and QTRAP systems—targeted metabolomics offers unmatched sensitivity, dynamic range, and reproducibility. This quantitative rigor makes it the method of choice for validation studies, clinical biomarker identification, and industrial quality control.
Targeted metabolomics bypasses the complex data-deconvolution stages of untargeted profiling, delivering absolute concentrations of target compounds with superior signal-to-noise ratios. This is crucial for clinical applications where precise biomarker thresholds dictate diagnostic outcomes.
In the rapidly evolving scientific ecosystem of Ho Chi Minh City (HCMC), Vietnam, the demand for targeted metabolomics has experienced exponential growth. As the nation pushes forward with its national bio-economy initiatives, local universities, clinical research centers, and agricultural companies are increasingly leveraging these advanced analytical techniques to answer complex biological questions. This guide explores the current commercial and industrial landscape of targeted metabolomics in Ho Chi Minh City, outlines its localized application scenarios, analyzes key development trends, and provides a detailed framework for understanding service pricing.
Ho Chi Minh City, the economic powerhouse of Vietnam, is rapidly transforming into a regional hub for biotechnology and life sciences. The local government has heavily invested in infrastructure to support high-tech research, most notably through the expansion of the Saigon Hi-Tech Park (SHTP) and the establishment of dedicated biotechnology departments within major academic institutions. Key players in this academic and industrial ecosystem include Vietnam National University Ho Chi Minh City (VNU-HCM), the University of Medicine and Pharmacy at Ho Chi Minh City, and the Biotechnology Center of Ho Chi Minh City (Biotech Center HCMC).
Historically, biological research in Vietnam focused primarily on classical genetics and basic biochemistry. However, with the global shift towards precision medicine and smart agriculture, there is a critical need to understand the functional phenotypes of organisms. Metabolomics, which directly reflects the physiological state of a cell, tissue, or organism, has emerged as the vital link between genotype and phenotype. The commercial market in HCMC is characterized by a mix of local diagnostic laboratories, university-affiliated core facilities, and global multi-omics service providers. While local facilities often handle basic sample preparation and standard liquid chromatography-mass spectrometry (LC-MS) assays, complex high-throughput targeted metabolomics projects are frequently outsourced to international leaders like Biomarker Technologies (BMKGene).
These partnerships allow Vietnamese researchers to access cutting-edge instrumentation—such as ultra-high performance liquid chromatography coupled with triple quadrupole mass spectrometry (UHPLC-QQQ-MS) and QTRAP 6500+ systems—without the prohibitive capital expenditure of purchasing and maintaining such platforms locally. This hybrid model has accelerated scientific discovery in Southern Vietnam, enabling local researchers to publish in high-impact international journals and develop localized solutions for agriculture and healthcare.
The application of targeted metabolomics in Ho Chi Minh City is deeply tied to the region's unique economic, geographical, and clinical characteristics. Three main areas stand out as primary drivers of metabolomics research in the region:
The Mekong Delta, located just south of Ho Chi Minh City, is the agricultural heartland of Vietnam and one of the world's most productive zones for rice, shrimp, and pangasius catfish cultivation. As climate change accelerates, local agriculture faces severe threats from soil salinization, rising temperatures, and emerging pathogens. Targeted metabolomics is being deployed by regional research institutes to profile metabolic changes in salinity-resistant rice strains and to study the immune response of whiteleg shrimp (Litopenaeus vannamei) to white spot syndrome virus (WSSV). By identifying key biomarkers associated with stress tolerance or disease resistance, local breeders can accelerate the selection of robust varieties, securing Vietnam's vital food exports.
Ho Chi Minh City houses some of Vietnam's largest and most advanced clinical networks, including Cho Ray Hospital, the University Medical Center, and the HCMC Oncology Hospital. Clinical researchers in these institutions are actively utilizing targeted metabolomics to study metabolic reprogramming in cancer, cardiovascular diseases, and type 2 diabetes—a growing public health concern in urban Vietnam. For instance, profiling plasma amino acids and lipid classes allows clinicians to identify early-stage biomarkers for hepatocellular carcinoma (HCC), which has a high prevalence in the country. Additionally, targeted assays are used to monitor patient responses to chemotherapy, enabling personalized therapeutic adjustments based on metabolic clearance rates.
Vietnam possesses a rich heritage of traditional medicine, relying on thousands of native medicinal plant species. Ho Chi Minh City serves as the primary commercial hub for the processing and distribution of these herbal remedies. However, ensuring consistent quality, efficacy, and safety has historically been a challenge. Targeted metabolomics offers a robust solution by allowing the precise quantification of active bioactive compounds, such as ginsenosides in Vietnamese Ginseng (Panax vietnamensis) or curcuminoids in local turmeric varieties. By establishing metabolic fingerprints, local pharmaceutical companies can standardize their products, fulfill international regulatory requirements, and tap into the lucrative global wellness market.
As the biotechnology sector in Southern Vietnam matures, several key trends are shaping the future of metabolomics and multi-omics research in Ho Chi Minh City:
Researchers are moving away from single-technology studies. Modern projects in HCMC increasingly combine targeted metabolomics with genomics, transcriptomics, and proteomics. This multi-omics approach provides a holistic, multi-dimensional view of biological systems. For example, combining metagenomic sequencing of the human gut microbiome with targeted short-chain fatty acid (SCFA) profiling helps researchers understand how dietary changes influence metabolic health in the local population.
High-throughput workflows require high reproducibility. The adoption of automated liquid handling platforms, such as the Brilliant Lab 1000 (BL1000) developed in partnership between BMKGene and PerkinElmer, is revolutionizing library preparation and sample extraction. Automation minimizes human error, reduces batch effects, and significantly decreases turnaround times, allowing large-scale population studies to be completed within weeks rather than months.
The massive datasets generated by high-resolution mass spectrometers require sophisticated computational tools for alignment, peak detection, and biological pathway mapping. Local research laboratories in HCMC often lack the high-performance computing (HPC) infrastructure needed for this level of analysis. The utilization of secure, user-friendly cloud platforms like BMKCloud bridges this gap. BMKCloud offers pre-configured pipelines, high computing power (with peak computing power over 121,708.8 Gflop per second), and intuitive visualization tools, allowing local scientists to perform complex bioinformatics tasks directly from a standard web browser.
Biomarker Technologies (BMKGene), founded in 2009, is a leading genomics service provider with over 16 years of continuous innovation in high-throughput sequencing and bioinformatics. Backed by more than 60 national invention patents and 200+ software copyrights, we deliver comprehensive multi-omics solutions—spanning genomics, metagenomics, epigenetics, single-cell omics, transcriptomics, and our proprietary BMKMANU S3000 spatial transcriptome technology—supported by our advanced BMKCloud bioinformatics platform. We have established long-term collaborations with organizations across 84 regions worldwide, providing reliable genomic solutions on a global scale.
Biomarker technologies (BMKGENE) and PerkinElmer have jointly built a fully automated experimental production line, called Brilliant Lab 1000 (BL1000), which is applied to the high-throughput NGS library construction service.
BMKGENE strives to greatly improve the entire line of sequencing products in terms of product types, production line throughput, delivery quality, and cycle time, to provide customers with better sequencing services.









When planning a targeted metabolomics project in Ho Chi Minh City, researchers must navigate various pricing models. The cost of targeted metabolomics services is determined by several critical factors:
The physical nature of the sample dictates the preparation effort. Liquid samples like serum, plasma, and urine are relatively simple to extract and analyze, leading to lower per-sample costs. Conversely, solid tissues, plant materials, soil, or fecal samples require specialized homogenization, cell disruption, and multi-step extraction procedures to isolate specific metabolite classes, which increases the labor and material costs.
Standardized panels (e.g., amino acids, organic acids, central carbon metabolites, or bile acids) are highly cost-effective because the chromatographic methods and calibration curves are pre-validated. Custom panels, which require the acquisition of chemical standards, method development, and validation of specific transitions on a triple quadrupole mass spectrometer, involve significant setup fees but offer tailored insights for niche research areas.
The choice of mass spectrometer affects both the price and the data quality. Assays performed on industry-standard platforms like the Waters XEVO G2-XS QTOF or the QTRAP 6500+ offer superior sensitivity and resolution, which may command a premium compared to older-generation LC-MS systems.
Basic pricing usually covers raw data delivery and peak area integration. Advanced bioinformatics package upgrades—including multivariate statistical analysis (PCA, PLS-DA), pathway enrichment analysis, and integration with transcriptomic or metagenomic datasets—add to the total project cost but save valuable time for research teams.
Large-scale projects benefit from significant economies of scale. Service providers typically offer tiered pricing, with substantial discounts for batches exceeding 50 or 100 samples, as this allows for more efficient run scheduling and calibration standard usage.
Our commitment to quality is backed by international certifications and patents, ensuring the highest standards of data accuracy and operational excellence.
Explore our full suite of sequencing and multi-omics services. Combine these genomic and transcriptomic products with metabolomics to achieve deep biological insights.
Our technical team will analyze your project requirements and get in touch within 24 hours.
Inquiry Now